523 Nivolumab and ipilimumab in patients with metastatic non-clear cell renal cell carcinoma at MD Anderson Cancer Center

• Jianjun Gao,
• Pavlos Msaouel,
• Nizar Tannir,
• Eric Jonasch,
• Matthew Campbell,
• Amishi Shah,
• Priya Rao,
• Omar Alhalabi,
• Sangeeta Goswami,
• Nathaniel Wilson,
• Elshad Hasanov,
• Jaanki Khandelwal,
• Devaki S Surasi,
• Sergio P Klimkowsky,
• Mohammad J Moussa,
• Andrew Hahn,
• Kanishka Sircar

Affiliations

Jianjun Gao

assistant professor of medicine

Pavlos Msaouel

3 Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Nizar Tannir

Aff11 grid.240145.60000000122914776MD Anderson Houston TX USA

Eric Jonasch

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Matthew Campbell

School of Food Science and Nutrition, University of Leeds, Leeds, West Yorkshire, UK

Amishi Shah

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Priya Rao

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Omar Alhalabi

Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Sangeeta Goswami

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Nathaniel Wilson

1University of Texas Health Science Center-Houston, Houston, TX, USA

Elshad Hasanov

2University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jaanki Khandelwal

1University of Texas Health Science Center-Houston, Houston, TX, USA

Devaki S Surasi

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Sergio P Klimkowsky

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Mohammad J Moussa

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Andrew Hahn

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kanishka Sircar

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA